X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Pureos Bioventures Expands the Team by the Appointment of Venture Partners

Content Team by Content Team
21st September 2021
in News
Pureos Bioventures Expands the Team by the Appointment of Venture Partners

Pureos Bioventures, a venture capital fund dedicated to support private biotech companies developing novel therapies, announced the appointment of several venture partners to its team. The first-time fund has USD 205 million under management and has invested in 11 private biotech companies so far. In addition, Pureos is a partner at BaseLaunch, an incubator of biotech startups in Basel, Switzerland. First portfolio companies of Pureos Bioventures have already gone public or have been acquired.

As new venture partners Dr. Dragan Grabulovski, Ian Metcalfe and Dr. Roberto Iacone have joined the team as of 1st September. Dragan was CSO and co-founder of Covagen AG, a Swiss biotech company focusing on bispecific antibodies and antibody alternatives. Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson acquired Covagen in 2014. Since 2015 Dragan is an independent advisor to biotech start-ups, coach at the ETH Zurich and Innosuisse (Swiss Innovation Agency), board member and entrepreneur.

Ian joined NovaGo Therapeutics as CEO in 2020. Before NovaGo, Ian worked as Chief Operating Officer for Corlieve Therapeutics, which was acquired by uniQure in July 2021. Prior to that, Ian held positions of increasing responsibility at both Roche and Nestlé, including Investor Relations, business development/M&A, Global Product Strategy, and late stage Pharma Development. Ian’s earlier career involved his own start-up enterprise, playing a key role in Berna Biotech’s R&D group, and raising funds for the Sicilian based start-up Etna Biotech.

Roberto is CEO of Alentis Therapeutics, a physician-scientist (MD PhD) and biotech entrepreneur who has advanced several assets to early clinical development. He has strong translational medicine and strategic experience across rare Diseases, fibrosis, immunology, and oncology. Prior to Alentis, Roberto was part of the leadership team which built Black Diamond Therapeutics from inception through multiple financing rounds and to a NASDAQ IPO. Before that he was heading rare diseases research at Roche.

Managing Partners of Pureos Klaus Breiner, Dominik Escher, and Martin Münchbach stated: “We are very pleased to welcome Dragan, Ian and Roberto as our venture partners. They bring tremendous additional experience of building biotech companies to Pureos, which will help the fund to start up and foster our portfolio companies.”

Previous Post

Pharmapack Europe: Innovation, Networking and Education

Next Post

Omya showcases multifunctional mineral excipients and active ingredients

Related Posts

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Clinical Trials

Cancer Clinical Trials Get A Brand New Platform In Melbourne

3rd November 2022
Next Post
Omya showcases multifunctional mineral excipients and active ingredients

Omya showcases multifunctional mineral excipients and active ingredients

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In